ACCELERON PHARMA
Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and functi... on in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis. It develops therapies based on growth and differentiation factors that regulate the cellular proliferation, differentiation, and survival of a range of tissue types. The company offers treatments for cancer-related bone loss, cancer-related muscle loss, neuromuscular diseases, and metabolic disorders. Acceleron Pharma, Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.
ACCELERON PHARMA
Industry:
Biotechnology Health Care Manufacturing Medical Pharmaceutical
Founded:
2004-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.acceleronpharma.com
Total Employee:
251+
Status:
Active
Contact:
617-649-9200
Email Addresses:
[email protected]
Total Funding:
987.01 M USD
Technology used in webpage:
SPF IPv6 ReCAPTCHA Cloudflare JS CDN JS Cloudflare Cloudflare Hosting Cloudflare SSL ReCAPTCHA V2 Amazon S3
Similar Organizations
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Repligen
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
Rubius Therapeutics
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
NIIMBL
The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Novaliq
Novaliq is a pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics.
Nexgel
NEXGEL is a biotechnology company that engages in a trans-dermal delivery system.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Veloxis
Veloxis is a speciality pharmaceutical company focused on the development and commercialization of Envarsus.
The Valens Company
The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.
Viriom
Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.
Vivacitas Oncology
Vivacitas Oncology is a biopharmaceutical company with a focus on combating cancers resistant to current treatment modalities.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Medicure
Medicure is a specialty pharmaceutical Company engaged in the research, clinical development and commercialization of human therapeutics.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
Mingsight Pharmaceuticals
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Atlantic Healthcare
A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Aerogen
Aerogen is a medical device and drug delivery company.
Anacor Pharmaceutical
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
First Wave BioPharma
First Wave BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies.
Eiger BioPharmaceuticals
Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Entasis Therapeutics
Entasis Therapeutics is developing a portfolio of innovative cures.
Berry Genomics
Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
FAPON
FAPON is a biotechnology company that provides IVD reagent raw material manufacturing and a one-stop solution.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Fagron SA
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCâ„¢ platform.
TissueGene
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders.
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.
JA Saúde Animal
J.A Saúde Animal specializes in research, development, manufacturing, and commercialization of products for animal health.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
QuVa Pharma
QuVa Pharma is a quality-compliant manufacturer of compounded and ready-to-administer sterile injectable products.
Kolltan Pharmaceuticals
Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Humanigen
Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Windgap Medical
WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies.
SelfDiagnostics
Selfdiagnostics is an Estonian/German company with the purpose of developing and marketing medical point-of-care (POC) diagnostics devices.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Secura Bio
Secura Bio is an integrated biopharmaceutical company committed to giving patients access to innovative therapies.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
scPharmaceuticals
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Holobiome
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
Haemalogix
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
IntelGenX
IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.
Ionetix
Ionetix is a pioneering end-to-end radiopharmaceutical provider for cardiac PET imaging.
Intas Pharmaceuticals
Intas Pharmaceuticals is a global pharmaceutical formulation development, manufacturing and marketing company.
Immuneering
Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
OxyNov inc
OxyNov focuses on clinical innovation and specializes in designing and commercializing innovative medical devices.
Oncolix
Oncolix is a clinical-stage bio-pharmaceutical company developing a therapeutic protein for the treatment of cancer.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
Canntab Therapeutics
Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
Covance
Covance is a global contract research organization and drug development services company.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Cydan
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Nuo Therapeutics
Nuo Therapeutics develops biological therapies to address the areas of wound care, inflammation, and angiogenesis.
Constellation Pharmaceuticals
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Apollomics
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Pneuma Respiratory
Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery.
Prism Pharmaceuticals
Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Provention Bio
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Protalix BioTherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Proteon Therapeutics
Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.
Pharmaca
Pharmaca offers traditional pharmacy services as well as holistic remedies, providing over-the-counter medicines and alternative remedies.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Celgene
Celgene investment in Series D - Acceleron Pharma
Venrock
Venrock investment in Venture Round - Acceleron Pharma
OrbiMed
OrbiMed investment in Venture Round - Acceleron Pharma
Flagship Pioneering
Flagship Pioneering investment in Venture Round - Acceleron Pharma
Polaris Partners
Polaris Partners investment in Venture Round - Acceleron Pharma
Advanced Technology Ventures
Advanced Technology Ventures investment in Venture Round - Acceleron Pharma
Flagship Pioneering
Flagship Pioneering investment in Series C - Acceleron Pharma
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Acceleron Pharma
OrbiMed
OrbiMed investment in Series C - Acceleron Pharma
MPM Capital
MPM Capital investment in Series C - Acceleron Pharma
Official Site Inspections
http://www.acceleronpharma.com
- Host name: ad8242ffdb37e18fd.awsglobalaccelerator.com
- IP address: 99.83.236.178
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Acceleron Pharma"
Learn About Acceleron
Acceleron is an organization that values diversity, equity, and inclusion (DE&I). We strive to promote an inclusive culture in which our employees and the global population we serve feel …See details»
Acceleron Pharma - Wikipedia
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. See details»
Acceleron Pharma - Crunchbase Company Profile & Funding
Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the …See details»
Welcome to Acceleron Clinical Trials
Information about what is provided on the website for Patients and Healthcare Professional and Acceleron´s clinical trial transparency commitmentSee details»
Acceleron Pharma - LinkedIn
Acceleron Pharma | 18,726 followers on LinkedIn. Accelerating drug discovery to transform patients' lives | Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of …See details»
Acceleron Pharma Company Overview, Contact Details
Jun 30, 2020 Acceleron Pharma Inc. launches drug in the first-line setting for MDS. Reblozyl has already achieved more than satisfactory sales since its launch, and as per DelveInsight's …See details»
Working At Acceleron Pharma: Company Overview and Culture
Mar 14, 2024 acceleronpharma.com. Organization Type. Public. CEO. Habib J. Dable. Social Media. Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company …See details»
Acceleron Pharma Inc - Company Profile - GlobalData
Website www.acceleronpharma.com Telephone 1 617 6499200. No of Employees 312. Industry Pharmaceuticals and Healthcare. Revenue (2020) $92.5M Gain access to our ...See details»
Acceleron Pharma - Craft
Acceleron Pharma $92.52 m in annual revenue in FY 2020. See insights on Acceleron Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Information for Healthcare Providers - Acceleron Pharma Inc.
Acceleron Pharma Inc. welcomes talented, experienced physicians to share their interest in potentially becoming Principal Investigators in Acceleron-sponsored clinical trials.See details»
Acceleron Pharma | XLRN Stock Price, Company Overview & News
Merck yesterday announced that it will acquire Acceleron Pharma - a biopharmaceutical company focused on rare diseases - for $11.5 billion funded in cash and debt.See details»
Merck Completes Acquisition of Acceleron Pharma Inc.
Nov 22, 2021 Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. …See details»
Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.
Oct 12, 2021 Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding …See details»
Merck to Acquire Acceleron Pharma Inc. - Nasdaq
Sep 30, 2021 Copies of the documents filed with the SEC by Acceleron may be obtained at no charge on Acceleron’s internet website at www.acceleronpharma.com or by contacting …See details»
Merck to buy Acceleron for about $11.5 bln in rare disease drug …
Sep 30, 2021 Merck & Co said on Thursday it would buy Acceleron Pharma Inc for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments …See details»
Learn about Clinical trials
The person(s) or organization who initiates and funds the clinical trial. The Site. A location where the clinical trial is being conducted, including hospitals, universities, clinics, and doctors’ …See details»
Merck to Acquire Acceleron Pharma Inc. - Merck.com
Sep 30, 2021 Copies of the documents filed with the SEC by Acceleron may be obtained at no charge on Acceleron’s internet website at www.acceleronpharma.com or by contacting …See details»
Acceleron Appoints Laura J. Hamill to its Board of Directors
Sep 16, 2020 Contacts. Acceleron Pharma Inc. Investors: Jamie Bernard, IRC, 617-649-9650 Associate Director, Investor Relations Media: Matt Fearer, 617-301-9557 Director, Corporate …See details»
Merck to Acquire Acceleron Pharma Inc. - Business Wire
Sep 30, 2021 Copies of the documents filed with the SEC by Acceleron may be obtained at no charge on Acceleron’s internet website at www.acceleronpharma.com or by contacting …See details»
Acceleron Reports Second Quarter 2021 Financial Results
Aug 5, 2021 The webcast will be accessible under "Events & Presentations" in the Investors & Media page of the Company’s website at www.acceleronpharma.com. To participate in the …See details»